Risk of dementia among white and African American relatives of patients with Alzheimer disease

JAMA

Volumn 287, Issue 3, 2002, Pages 329-336

  Green, Robert C ^a   Cupples, L Adrienne ^b   Go, Rodney ^c   Benke, Kelly S ^a   Edeki, Timi ^d   Griffith, Patrick A ^d   Williams, Mary ^d   Hipps, Yvonne ^d   Graff Radford, Neill ^e   Bachman, David ^f   Farrer, Lindsay A ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

^e MAYO CLINIC   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; GENDER; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEGRO; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; RISK FACTOR;

EID: 0037116658     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.3.329     Document Type: Article

References (40)

1. Genetics and the dementia patient
2. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis
3. Genetic transmission for Alzheimer's disease among families in a Dutch population based survey
4. Patterns of risk in first-degree relatives of patients with Alzheimer's disease
5. Apolipoprotein E genotype in patients with Alzheimer's disease: Implications for the risk of dementia among relatives
6. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?
7. The incidence of dementia: A meta-analysis
8. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis
9. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana
10. Association between APOE genotype and Alzheimer disease in African Americans
11. Interrater agreement for diagnosis of Alzheimer's disease: The MIRAGE study
12. Reliability of information collected by proxy in family studies of Alzheimer's disease
13. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group
14. Head injury and the risk of Alzheimer disease in the MIRAGE study
15. The telephone interview for cognitive status
16. Detection of dementia in the elderly using telephone screening of cognitive status
17. Apolipoprotein E genotyping by one-stage PCR
18. Estimation of morbid risk and age at onset with missing information
19. Influence of APOE genotype on familial aggregation of AD in an urban population
20. Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhatten
21. Health, double jeopardy, and culture: The use of institutionalization by African-Americans
22. Recruitment of black elderly for clinical research studies of dementia: The CERAD experience
23. Racial, ethnic and cultural differences in dementia caregiving: Review and analysis
24. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias
25. Validity of family history for the diagnosis of dementia among siblings of patients with late-onset Alzheimer's disease
26. Rates of dementia in three ethnoracial groups
27. The APOE-e4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics
28. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan
29. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks
30. Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease
31. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent
32. Lack of an association between Apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians
33. Apollpiprotein E polymorphism in elderly East Africans
34. Statement on use of Apolipoprotein E testing for Alzheimer disease
35. The genetics of Alzheimer's disease: New opportunities and new challenges
36. Consensus statement on predictive testing for Alzheimer disease
37. Consensus statements on the use of APOE genotyping in Alzheimer's disease
38. The clinical introduction of genetic testing for Alzheimer's disease: An ethical perspective
39. Genetic testing and Alzheimer disease: Has the time come?